Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Purva Bulsara"'
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101440- (2024)
Objective: Previous studies have shown that first-line (1L) maintenance therapy (MT) with poly(ADP-ribose) polymerase inhibitors and/or bevacizumab improves outcomes among patients with advanced ovarian cancer (OC); however, these treatments are unde
Externí odkaz:
https://doaj.org/article/62aca536a8d045baba07fd6e15b603ae
Autor:
Shivendra Singh, Ahmed Abu-Zaid, Wenwei Lin, Jonathan Low, Alireza Abdolvahabi, Hongjian Jin, Qiong Wu, Bailey Cooke, Jie Fang, John Bowling, Sivaraja Vaithiyalingam, Duane Currier, Mi-Kyung Yun, Dinesh M. Fernando, Julie Maier, Heather Tillman, Purva Bulsara, Zhaohua Lu, Sourav Das, Anang Shelat, Zhenmei Li, Brandon Young, Richard Lee, Zoran Rankovic, Andrew J. Murphy, Stephen W. White, Andrew M. Davidoff, Taosheng Chen, Jun Yang
Publikováno v:
iScience, Vol 24, Iss 1, Pp 101996- (2021)
Summary: Histone lysine demethylases (KDMs) play critical roles in oncogenesis and therefore may be effective targets for anticancer therapy. Using a time-resolved fluorescence resonance energy transfer demethylation screen assay, in combination with
Externí odkaz:
https://doaj.org/article/06c582be98bb44abbf752e112dc13534
Autor:
Dana Chase, Jinan Liu, Laura Moore-Schiltz, Jennifer Perhanidis, Purva Bulsara, Gregory Patton
Publikováno v:
Featured Printed Posters (Poster Rounds with the Professors).
Autor:
Clara Krystal Perez Fermin, Estuardo Pineda, Carlos Rodriguez-Galindo, Angela K. Carrillo, Tania Huitz, Scheybi Miralda, Zhaohua Lu, Erika Montalvo, Claudia Del Real, Patricia Calderón, Rosdali Díaz, Octavia Negrín, Adolfo Cardenas, Angélica Martínez, Maria Susana Juárez Tobias, Dora Soberanis, Purva Bulsara, Claudia de León, Marcela Garza, Manuel Alvarado, Alejandra Osuna, Asya Agulnik, Yvania Alfonso Carreras
Publikováno v:
Cancer
Background Hospitalized pediatric hematology‐oncology (PHO) patients have frequent clinical deterioration events (CDE) requiring intensive care unit (ICU) admission, particularly in resource‐limited settings. The objective of this study was to de
Publikováno v:
Paediatric anaesthesiaREFERENCES. 31(5)
Perianesthetic neurological adverse events are rare in children and have been studied in detail in the settings of cardiac surgery and regional anesthesia. Our study aims to characterize perianesthetic neurological adverse events in children in the s
Autor:
Ahmed Abu-Zaid, Sivaraja Vaithiyalingam, Brandon Young, Sourav Das, Heather Tillman, Bailey Cooke, Alireza Abdolvahabi, Julie Maier, Jonathan Low, Taosheng Chen, Jun J. Yang, Andrew M. Davidoff, Zhenmei Li, John J. Bowling, Hongjian Jin, Shivendra V. Singh, Jie Fang, Purva Bulsara, Wenwei Lin, Zoran Rankovic, Duane G. Currier, Andrew J. Murphy, Zhaohua Lu, Richard E. Lee, Anang A. Shelat, Dinesh M. Fernando, Qiong Wu, Stephen W. White, Mi-Kyung Yun
Publikováno v:
iScience
iScience, Vol 24, Iss 1, Pp 101996-(2021)
iScience, Vol 24, Iss 1, Pp 101996-(2021)
Summary Histone lysine demethylases (KDMs) play critical roles in oncogenesis and therefore may be effective targets for anticancer therapy. Using a time-resolved fluorescence resonance energy transfer demethylation screen assay, in combination with
Autor:
Jonathan Low, Brandon Young, Jun J. Yang, John J. Bowling, Zoran Rankovic, Dinesh M. Fernando, Andrew M. Davidoff, Zhenmei Li, Bailey Cooke, Duane G. Currier, Stephen W. White, Jie Fang, Ahmed Abu-Zaid, Julie Maier, Heather Tillman, Zhaohua Lu, Sourav Das, Shivendra V. Singh, Taosheng Chen, Sivaraja Vaithiyalingam, Purva Bulsara, Wenwei Lin, Richard E. Lee, Alaa Altahan, Mi-Kyung Yun, Alireza Abdolvahabi
Histone lysine demethylases (KDMs) are emerging as therapeutic targets in cancer. Development of potent KDM inhibitors may provide additional options for epigenomics-oriented therapies. Using a Time-Resolved Fluorescence Resonance Energy Transfer (TR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1ac2240ce64466e93c8e36ffb99c2a